Organogenesis Holdings Stock Buy Hold or Sell Recommendation
| ORGO Stock | USD 5.01 0.24 4.57% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Organogenesis Holdings is 'Strong Hold'. The recommendation algorithm takes into account all of Organogenesis Holdings' available fundamental, technical, and predictive indicators you will find on this site.
Check out Organogenesis Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide. In addition, we conduct extensive research on individual companies such as Organogenesis and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Organogenesis Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Organogenesis |
Execute Organogenesis Holdings Buy or Sell Advice
The Organogenesis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Organogenesis Holdings. Macroaxis does not own or have any residual interests in Organogenesis Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Organogenesis Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Modest | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Organogenesis Holdings Trading Alerts and Improvement Suggestions
| Organogenesis Holdings is way too risky over 90 days horizon | |
| Organogenesis Holdings appears to be risky and price may revert if volatility continues | |
| Organogenesis Holdings has a strong financial position based on the latest SEC filings | |
| About 47.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 81000 shares by Robert Cavorsi of Organogenesis Holdings at 2.51 subject to Rule 16b-3 |
Organogenesis Holdings Returns Distribution Density
The distribution of Organogenesis Holdings' historical returns is an attempt to chart the uncertainty of Organogenesis Holdings' future price movements. The chart of the probability distribution of Organogenesis Holdings daily returns describes the distribution of returns around its average expected value. We use Organogenesis Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Organogenesis Holdings returns is essential to provide solid investment advice for Organogenesis Holdings.
| Mean Return | 1.06 | Value At Risk | -7.34 | Potential Upside | 6.74 | Standard Deviation | 13.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Organogenesis Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Organogenesis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Organogenesis Holdings, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Organogenesis Holdings back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-12-31 | 925.7 K | D. E. Shaw & Co Lp | 2024-12-31 | 737.4 K | Goldman Sachs Group Inc | 2024-12-31 | 656.2 K | Northern Trust Corp | 2024-12-31 | 616.1 K | Bank Of America Corp | 2024-12-31 | 519.1 K | Two Sigma Advisers, Llc | 2024-12-31 | 489 K | Norges Bank | 2024-12-31 | 482.2 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-12-31 | 459.5 K | Bank Of New York Mellon Corp | 2024-12-31 | 418.8 K | Soleus Capital Management, L.p. | 2024-12-31 | 12.5 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 11.8 M |
Organogenesis Holdings Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (6.7M) | (9.3M) | (9.4M) | 6.6M | 8.2M | 8.6M | |
| Investments | (24.8M) | (31.2M) | (33.9M) | (31.7M) | (10.0M) | (10.5M) | |
| Change In Cash | 24.4M | 29.7M | (11.2M) | 1.0M | 31.8M | 33.4M | |
| Net Borrowings | 38.1M | (15.9M) | 2.2M | (2.8M) | (2.5M) | (2.4M) | |
| Depreciation | 7.5M | 16.7M | 18.0M | 23.4M | 17.0M | 12.0M | |
| Capital Expenditures | 21.1M | 31.2M | 33.9M | 24.4M | 10.0M | 13.4M | |
| Net Income | 17.9M | 94.9M | 15.5M | 4.9M | 861K | 904.1K | |
| End Period Cash Flow | 84.8M | 114.5M | 103.3M | 104.3M | 136.2M | 143.0M | |
| Change To Netincome | 7.2M | 7.5M | (25.5M) | 15.2M | 13.7M | 14.4M | |
| Free Cash Flow | (14.3M) | 30.8M | (9.0M) | 6.6M | 4.2M | 4.4M | |
| Other Non Cash Items | 5.8M | 17.8M | 16.8M | 9.6M | (3.5M) | (3.7M) |
Organogenesis Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Organogenesis Holdings or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Organogenesis Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Organogenesis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.61 | |
β | Beta against Dow Jones | 5.09 | |
σ | Overall volatility | 14.01 | |
Ir | Information ratio | 0.09 |
Organogenesis Holdings Volatility Alert
Organogenesis Holdings is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Organogenesis Holdings' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Organogenesis Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Organogenesis Holdings Fundamentals Vs Peers
Comparing Organogenesis Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Organogenesis Holdings' direct or indirect competition across all of the common fundamentals between Organogenesis Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as Organogenesis Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Organogenesis Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing Organogenesis Holdings by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Organogenesis Holdings to competition |
| Fundamentals | Organogenesis Holdings | Peer Average |
| Return On Equity | 0.0026 | -0.31 |
| Return On Asset | 0.0281 | -0.14 |
| Profit Margin | 0 % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 664.93 M | 16.62 B |
| Shares Outstanding | 126.83 M | 571.82 M |
| Shares Owned By Insiders | 46.65 % | 10.09 % |
| Shares Owned By Institutions | 49.75 % | 39.21 % |
| Number Of Shares Shorted | 8.67 M | 4.71 M |
| Price To Earning | 17.12 X | 28.72 X |
| Price To Book | 2.41 X | 9.51 X |
| Price To Sales | 1.32 X | 11.42 X |
| Revenue | 482.04 M | 9.43 B |
| Gross Profit | 366.3 M | 27.38 B |
| EBITDA | (1.28 M) | 3.9 B |
| Net Income | 861 K | 570.98 M |
| Cash And Equivalents | 113.24 M | 2.7 B |
| Cash Per Share | 0.87 X | 5.01 X |
| Total Debt | 43.31 M | 5.32 B |
| Debt To Equity | 0.52 % | 48.70 % |
| Current Ratio | 2.62 X | 2.16 X |
| Book Value Per Share | 2.09 X | 1.93 K |
| Cash Flow From Operations | 14.21 M | 971.22 M |
| Short Ratio | 2.90 X | 4.00 X |
| Earnings Per Share | (0.01) X | 3.12 X |
| Price To Earnings To Growth | 6.15 X | 4.89 X |
| Target Price | 6.0 | |
| Number Of Employees | 869 | 18.84 K |
| Beta | 1.66 | -0.15 |
| Market Capitalization | 635.41 M | 19.03 B |
| Total Asset | 497.89 M | 29.47 B |
| Retained Earnings | (40.11 M) | 9.33 B |
| Working Capital | 208.46 M | 1.48 B |
Note: Disposition of 81000 shares by Robert Cavorsi of Organogenesis Holdings at 2.51 subject to Rule 16b-3 [view details]
Organogenesis Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Organogenesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Organogenesis Holdings Buy or Sell Advice
When is the right time to buy or sell Organogenesis Holdings? Buying financial instruments such as Organogenesis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Organogenesis Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cigarettes Thematic Idea Now
Cigarettes
Tobacco makers and distributors across globe. The Cigarettes theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Organogenesis Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.01) | Revenue Per Share | Quarterly Revenue Growth 0.271 | Return On Assets |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.